JP7823893B2 - グリコサミノグリカン（ｇａｇ）の経皮送達を増強するための方法 - Google Patents

グリコサミノグリカン（ｇａｇ）の経皮送達を増強するための方法

Info

Publication number
JP7823893B2
JP7823893B2 JP2022550773A JP2022550773A JP7823893B2 JP 7823893 B2 JP7823893 B2 JP 7823893B2 JP 2022550773 A JP2022550773 A JP 2022550773A JP 2022550773 A JP2022550773 A JP 2022550773A JP 7823893 B2 JP7823893 B2 JP 7823893B2
Authority
JP
Japan
Prior art keywords
starch
skin
kda
hyaluronic acid
complex
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2022550773A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023516924A5 (https=
JP2023516924A (ja
Inventor
シモノヴ，レア
コスト，ジョセフ
トライテル，タマル
ゴールドバート，リキ
Original Assignee
ビー．ジー．ネゲブ テクノロジーズ アンド アプリケーションズ リミテッド， アット ベン‐グリオン ユニバーシティー
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ビー．ジー．ネゲブ テクノロジーズ アンド アプリケーションズ リミテッド， アット ベン‐グリオン ユニバーシティー filed Critical ビー．ジー．ネゲブ テクノロジーズ アンド アプリケーションズ リミテッド， アット ベン‐グリオン ユニバーシティー
Publication of JP2023516924A publication Critical patent/JP2023516924A/ja
Publication of JP2023516924A5 publication Critical patent/JP2023516924A5/ja
Application granted granted Critical
Publication of JP7823893B2 publication Critical patent/JP7823893B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/732—Starch; Amylose; Amylopectin; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/82—Preparation or application process involves sonication or ultrasonication
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/91—Injection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2210/00—Anatomical parts of the body
    • A61M2210/04—Skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M37/0092—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin using ultrasonic, sonic or infrasonic vibrations, e.g. phonophoresis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Medical Informatics (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
JP2022550773A 2020-02-24 2021-02-24 グリコサミノグリカン（ｇａｇ）の経皮送達を増強するための方法 Active JP7823893B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202062980635P 2020-02-24 2020-02-24
US62/980,635 2020-02-24
PCT/IB2021/051558 WO2021171206A1 (en) 2020-02-24 2021-02-24 Methods for enhancing transdermal delivery of glycosaminoglycans (gags)

Publications (3)

Publication Number Publication Date
JP2023516924A JP2023516924A (ja) 2023-04-21
JP2023516924A5 JP2023516924A5 (https=) 2024-02-22
JP7823893B2 true JP7823893B2 (ja) 2026-03-04

Family

ID=77491814

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022550773A Active JP7823893B2 (ja) 2020-02-24 2021-02-24 グリコサミノグリカン（ｇａｇ）の経皮送達を増強するための方法

Country Status (4)

Country Link
US (1) US20230149683A1 (https=)
EP (1) EP4110284A4 (https=)
JP (1) JP7823893B2 (https=)
WO (1) WO2021171206A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2947097A1 (es) * 2022-02-01 2023-08-01 Martinez Miguel Angel Gomariz Metodo cosmetico de rejuvenecimiento de la piel
US20250017817A1 (en) * 2023-07-10 2025-01-16 John F. Warlick Acoustic shock wave treatment and devices for excess, sagging skin

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008515581A (ja) 2004-10-11 2008-05-15 ダーマグライア・リミテッド 皮膚状態を処置するための装置
US20150157728A1 (en) 2008-05-23 2015-06-11 Pankaj Modi Stabilized and solubilized drug formulation for topical application and transdermal efficacy for cosmetic improvement and methods of formulation
CN106726430A (zh) 2017-01-24 2017-05-31 北京欧扬医疗美容门诊部有限公司 一种基于聚焦超声技术的六层抗衰设备
JP2020002133A (ja) 2018-06-28 2020-01-09 ジョンソン・アンド・ジョンソン・コンシューマー・インコーポレイテッドＪｏｈｎｓｏｎ ＆ Ｊｏｈｎｓｏｎ Ｃｏｎｓｕｍｅｒ Ｉｎｃ． 光及びグルコサミン塩酸塩を使用して皮膚状態を治療するための組成物及び方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH705713B1 (de) * 2012-09-21 2013-05-15 Labo Cosprophar Ag Dermokosmetische Zusammensetzung zur topischen Anwendung.
DK3446742T3 (da) * 2013-03-15 2023-09-04 Carewear Corp Lysterapienhed
KR102540969B1 (ko) * 2015-04-01 2023-06-09 주식회사 파마리서치 소듐 2-메르캅토에탄 설포네이트를 함유하는 피부 재생 촉진용 조성물
KR101693753B1 (ko) * 2015-06-01 2017-01-06 서울과학기술대학교 산학협력단 pH 민감성 하이드록시에틸셀룰로오스-히알루론산 복합 하이드로젤 및 그 제조방법
ES2971884T3 (es) * 2016-10-17 2024-06-10 Pola Chem Ind Inc Partículas compuestas que incluyen polímero aniónico y polímero catiónico o péptido, y método para producir partículas compuestas
JP2021095361A (ja) * 2019-12-17 2021-06-24 ロレアル ヒアルロン酸系ポリイオンコンプレックス粒子を含む組成物

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008515581A (ja) 2004-10-11 2008-05-15 ダーマグライア・リミテッド 皮膚状態を処置するための装置
US20150157728A1 (en) 2008-05-23 2015-06-11 Pankaj Modi Stabilized and solubilized drug formulation for topical application and transdermal efficacy for cosmetic improvement and methods of formulation
CN106726430A (zh) 2017-01-24 2017-05-31 北京欧扬医疗美容门诊部有限公司 一种基于聚焦超声技术的六层抗衰设备
JP2020002133A (ja) 2018-06-28 2020-01-09 ジョンソン・アンド・ジョンソン・コンシューマー・インコーポレイテッドＪｏｈｎｓｏｎ ＆ Ｊｏｈｎｓｏｎ Ｃｏｎｓｕｍｅｒ Ｉｎｃ． 光及びグルコサミン塩酸塩を使用して皮膚状態を治療するための組成物及び方法

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Huan-Lei Wang et al.，Ultrasound-mediated transdermal drug delivery of fluorescent nanoparticles and hyaluronic acid into porcine skin in vitro，Chin. Phys. B，2016年，25 (12)，arn1243114

Also Published As

Publication number Publication date
EP4110284A1 (en) 2023-01-04
EP4110284A4 (en) 2024-03-20
US20230149683A1 (en) 2023-05-18
WO2021171206A1 (en) 2021-09-02
JP2023516924A (ja) 2023-04-21

Similar Documents

Publication Publication Date Title
Zhu et al. Applications and delivery mechanisms of hyaluronic acid used for topical/transdermal delivery–a review
Lapčík et al. Hyaluronan: preparation, structure, properties, and applications
Liao et al. Hyaluronan: pharmaceutical characterization and drug delivery
Noreen et al. Natural polysaccharide-based biodegradable polymeric platforms for transdermal drug delivery system: a critical analysis
Damiri et al. Smart stimuli-responsive polysaccharide nanohydrogels for drug delivery: a review
Weindl et al. Hyaluronic acid in the treatment and prevention of skin diseases: molecular biological, pharmaceutical and clinical aspects
Qi et al. Fabrication and characterization of a novel anticancer drug delivery system: salecan/poly (methacrylic acid) semi-interpenetrating polymer network hydrogel
Montanari et al. Hyaluronic acid nanohydrogels as a useful tool for BSAO immobilization in the treatment of melanoma cancer cells
EP3103485A1 (en) Material comprising a polymer capable of forming a hydrogel and nanoparticles
Priya et al. Colloidal chitin nanogels: A plethora of applications under one shell
Khvostov et al. Application of natural polysaccharides in pharmaceutics
US8202986B2 (en) Branched hyaluronic acid and method of manufacture
JP7823893B2 (ja) グリコサミノグリカン（ｇａｇ）の経皮送達を増強するための方法
KR102555193B1 (ko) 음이온 전하를 가진 키토산
Smejkalova et al. Hyaluronan (Hyaluronic Acid): a natural moisturizer for skin care
Raeisi et al. Mini review of polysaccharide nanoparticles and drug delivery process
Cho Lee Size matters: differential property of hyaluronan and its fragments in the skin-relation to pharmacokinetics, immune activity and wound healing
Abdel-Mottaleb et al. Versatile hyaluronic acid nanoparticles for improved drug delivery
Lopes et al. Application of chitosan based materials for drug delivery
US20250269089A1 (en) Self-healing injectable super-lubricating hydrogels and biomedical applications thereof
Lee et al. Advances in transdermal delivery systems using polysaccharide-based natural enhancers: mechanisms and clinical potential
Buckley et al. Hyaluronic Acid: A Review of the Drug Delivery Capabilities of This Naturally Occurring Polysaccharide. Polymers 2022, 14, 3442
Negut et al. Hyaluronic acid nanoparticles
Kim et al. Excipient-free nanotransformation of hydrophilic macromolecules using aqueous counter collision for enhanced bioavailability
Omer et al. High-molecular weight biopolymer

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20240214

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20240214

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20250122

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20250218

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20250515

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20250826

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20251125

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20260113

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20260212

R150 Certificate of patent or registration of utility model

Ref document number: 7823893

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150